ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,348(58.47%)
Declining
1,647(41.01%)
Unchanged
21(0.52%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc31.43526.69561.79%29,499,798
CERO LogoCEROCERo Therapeutics Holdings Inc3.06991.4488.34%21,522,776
XLO LogoXLOXilio Therapeutics Inc1.1750.53683.88%31,446,567
NXL LogoNXLNexalin Technologies Inc1.33060.550670.59%10,684,191
KYCH LogoKYCHKeyarch Acquisition Corporation11.934.9270.30%174,508
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.450.59168.80%85,901,854
MESO LogoMESOMesoblast Limited4.941.4541.55%13,347,116
XTKG LogoXTKGX3 Holdings Company Ltd0.820.239441.23%642,781
PIK LogoPIKKidpik Corporation4.50011.2337.62%9,381,172
BFRI LogoBFRIBiofrontera Inc1.54990.399934.77%235,090
GRDI LogoGRDIGRIID Infrastructure Inc1.350.3231.07%1,703,866
BOLD LogoBOLDBoundless Bio Inc14.54-45.43-75.75%637,555
PMEC LogoPMECPrimech Holdings Ltd1.275-2.61-67.14%7,480,471
GMDA LogoGMDAGamida Cell Ltd0.0364-0.0228-38.51%82,623,483
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.22-0.1069-32.70%17,724,756
KOD LogoKODKodiak Sciences Inc5.205-2.25-30.13%2,366,254
SLNA LogoSLNASelina Hospitality PLC0.164999-0.068-29.18%2,262,200
NDRA LogoNDRAENDRA Life Sciences Inc0.5981-0.2222-27.09%909,234
MVLA LogoMVLAMovella Holdings Inc0.056-0.0195-25.83%2,850,614
AKAN LogoAKANAkanda Corporation0.1225-0.0424-25.71%73,402,178
DTST LogoDTSTData Storage Corporation5.73-1.91-25.00%768,342
NKLA LogoNKLANikola Corporation1.0150.105911.65%150,003,713
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.450.59168.80%85,901,854
GMDA LogoGMDAGamida Cell Ltd0.0364-0.0228-38.51%82,623,483
MARA LogoMARAMarathon Digital Holdings Inc22.53220.46222.09%80,569,932
AKAN LogoAKANAkanda Corporation0.1225-0.0424-25.71%73,402,178
TSLA LogoTSLATesla Inc175.50-4.33-2.41%66,376,957
SQQQ LogoSQQQProShares UltraPro Short QQQ10.430.030.29%64,122,505
CISS LogoCISSC3is Inc0.0353-0.0029-7.59%62,497,047
AKBA LogoAKBAAkebia Therapeutics Inc1.815-0.425-18.97%58,014,392
AMD LogoAMDAdvanced Micro Devices Inc180.07480.48480.27%50,303,168
JAGX LogoJAGXJaguar Health Inc0.08410.011215.36%48,321,705
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
9097(34%)
Declining
2808(10%)
Unchanged
14443(56%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin70,734.491,269.921.83%1.39T5,924,400,454
ETHEthereum3,566.6066.541.90%428.98B3,011,796,586
USDTTether USD1.000.000560.06%97.84B778,178,608
BNBBinance Coin581.377.241.26%91.91B420,462,148
SOLSolana186.260.1400.08%82.26B1,299,865,812
STETHstETH3,556.3491.912.65%34.9B5,686,979
XRPRipple0.62780.01632.67%34.25B470,233,109
DOGEDogecoin0.224790.0347518.29%32.07B2,737,450,589
USDCUSD Coin1.000.000.00%28.07B1,323,830,752
ADACardano0.65030.00270.42%22.89B153,952,924

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar